December 10th & 11th, 2026
15th edition
MARSEILLE, FR
Stand E8

2017 Edition

InfiCure Bio

Sweden

InfiCure Bio has developed a new and unique pre-clinical mouse model, the N-IF mouse, which spontaneously develops fibrosis in multiple organs.
We offer expert led, tailored, high-quality drug validation services for R&D companies and CRO’s.
Our unique model offers extraordinary research advantages; is 100 percent reproducible, has a pathological progress similar to humans and displays a fibrosis preceded by inflammation.
Inficure Bio will break the status quo in anti-fibrotic drug development

Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.